Analyst firm restated rating and target price for CeriBell on September 10, 2026.
2 reports, 1 independent
Updated Sep 10
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firm restated rating and target price for CeriBell on September 10, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Analyst firms provided ratings and price targets for Merit Medical Systems on August 28, 2026, involving Raymond James Financial and Bank of America Corp.
- Analyst upgraded rating and set price target for Pound Medical, and Royal Bank of Canada increased its share holdings.
- Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.
- Keefe, Bruyette & Woods and Raymond James Financial upgraded the rating and target price for Invitation Homes shares on September 1, 2026.
- Bank of America and Raymond James Financial raised their ratings and increased price targets for Okta.